LEADER 03506cam a22003854a 4500
001 43534
003 OCoLC
005 20161229175918.0
008 010724s2001 sz a b 001 0 eng
020 |a 376435982X (alk. paper) 
040 |a TRMEMSKU 
049 |a TR7VH 
050 0 0 |a RC684.A53  |b ACE 2001 
072 7 |a RC  |2 lcco 
082 0 0 |a 616.1/061  |2 21 
245 0 0 |a ACE inhibitors /  |c edited by P. D'Orléans-Juste and G.E. Plante. 
260 |a Basel ;  |a Boston :  |b Birkhäuser Verlag,  |c c2001. 
300 |a x, 187 s. :  |b res. ;  |c 24 cm. 
440 0 |a Milestones in drug therapy  |9 188522 
504 |a Bibliyografya ve dizin var. 
505 8 |a Machine generated contents note: List of contributorsVII -- PrefaceIX -- John R. Vane -- The history of inhibitors of angiotensin converting enzyme1 -- Malika Lajemi and Athanase Benetos -- Genetics of the renin-angiotensin-aldosterone system and risk -- of arterial disease11 -- Paulus Wohlfart, Gabriele Wiemer, Wolfgang Linz and -- Bernward A. Scholkens -- Crosstalk between ACE inhibitors, B2 kinin receptor and nitric -- oxide in endothelial cells29 -- Rob L. Hopfner, J. Robert McNeill and Venkat Gopalakrishnan -- Interactions between the ACE and the endothelin pathway37 -- Maxime Lamarre-Cliche and Pierre Larochelle -- Evaluative and epidemiological approaches of ACE therapy47 -- Irene Gavras and Haralambos Gavras -- The role of ACE inhibition in heart failure71 -- Gdrard E. Plante and Tewfik Nawar -- Angiotensin converting enzyme inhibition in the microcirculation81 -- Michel E. Safar, Harry A.J. Struijker Boudier, Luc M.A.B. Van Bortel -- and Gdrard M. London -- Arterial structure and function and blockade of the renin- -- angiotensin system in hypertension105 -- Albert Adam, Charles Blais, Jr. and Francois Marceau -- The contribution of angiotensin-converting enzyme (ACE) to the -- metabolism of kinins (bradykinin and des-Arg9-bradykinin) and -- effect of ACE inhibitors on their in vitro and in vivo metabolism129 -- Jacques de Champlain and Pedro D'Orleans-Juste -- Role of the renin-angiotensin system on the central and -- peripheral autonomic nervous system145 -- Cynthia A. Fink -- Dual inhibitors of angiotensin converting enzyme and -- neutral endopeptidase155 -- Stylianos E. Orfanos, Linhua Zou and John D. Catravas -- Pharmacodynamics, tissue-specificity of ACE inhibitors163 -- Tewfik Nawar, Eve-Reine Gagne, Raymonde Turcotte and -- Gerard E. Plante -- Effect of angiotensin converting enzyme inhibition on thirst -- and salt-appetite171 -- Mark E. Cooper -- ACE and diabetes177 -- Subject index185. 
650 0 |a Angiotensin converting enzyme  |x Inhibitors.  |9 4822 
650 2 |a Angiotensin-Converting Enzyme Inhibitors  |x pharmacology.  |9 188523 
650 2 |a Angiotensin-Converting Enzyme Inhibitors  |x therapeutic use.  |9 188524 
650 2 |a Cardiovascular Diseases  |x drug therapy.  |9 188525 
650 4 |a Anjiyotensin - Değişen Enzim  |x İnhibitörler.  |9 188526 
650 2 2 |a Anjiyotensin - Değişen Enzim İhibiyörleri  |x Farmakoloji.  |9 188527 
650 2 2 |a Kardiyovasküler Hastalıklar  |x İlaç Tedavisi.  |9 188528 
700 1 |a D'Orléans-Juste, P.  |q (Pedro),  |d 1957-  |9 188529 
700 1 |a Plante, G. E.  |q (Gérard E.)  |9 188530 
856 4 1 |3 Table of contents  |u http://www.loc.gov/catdir/toc/fy022/2001043145.html 
994 |a C0  |b TR7VH 
942 |2 lcc 
999 |c 36985  |d 36985 
952 |0 0  |1 0  |2 lcc  |4 0  |5 0  |6 RC0684 A53 ACE 02001  |7 0  |9 56227  |a MK  |b MK  |c MK  |d 2005-11-01  |e S  |o RC684.A53 ACE 2001  |p 0072571  |r 2016-12-10  |t 1  |w 2005-11-01  |y KT